3 results match your criteria: "1University of Tennessee Health Science Center[Affiliation]"
Time to treatment of seizures is critical to efficacy. We performed a quality initiative and evaluated time to treatment of inpatient seizure emergencies with first- and second-line medicines before and after implementation of a computerized, standard treatment protocol. Data from 125 patients revealed that 179 seizure episodes required first-line antiepileptic drugs, and the mean time to treatment was 7.
View Article and Find Full Text PDFObjective: This study evaluated the efficacy and tolerability of modafinil at a range of doses, versus placebo, in alleviating symptoms of ADHD in adults.
Method: Adult patients with ADHD were randomized in 1:1:1:1:1 fashion to double-blind treatment with modafinil 255, 340, 425, or 510 mg daily or placebo for 9 weeks. The primary efficacy outcome was the change from baseline at final visit in the Adult ADHD Investigator Symptom Rating Scale (AISRS) total score.
Barriers to asthma treatment in the United States: results from the global asthma physician and patient survey.
World Allergy Organ J
December 2009
From the 1University of Tennessee Health Science Center, Memphis, TN; 2Institute for Asthma and Allergy, Chevy Chase, MD; 3Centre of Respiratory Medicine and Allergy. Chutro Clinic Córdoba, Córdoba, Argentina; 4Aarhus University Hospital, Department of Respiratory Diseases, Aarhus, Denmark; 5Turku Allergy Center, Turku, Finland; 6Allergy and Respiratory Diseases Clinic, University of Genova DIMI, Genova, Italy.
Background: : The Global Asthma Physician and Patient (GAPP) survey evaluated the perceptions of both physicians and patients on the management of asthma. Here we present the results from the United States (US) subpopulation of the GAPP survey.
Methods: : The GAPP Survey was a large, global study (physicians, n = 1733; patients, n = 1726; interviews, n = 3459).